Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
clinical trials
life sciences
national blog main
5
×
new york blog main
regeneron pharmaceuticals
5
×
amgen
boston top stories
inclisiran
national top stories
new york
new york top stories
alnylam pharmaceuticals
biotech
pcsk9 inhibitors
alirocumab
cholesterol
evolocumab
pcsk9
praluent
repatha
rna interference
sanofi
the medicines co.
adeno-associated virus
boston
cancer
chemotherapy
cisplatin
data
deals
decibel therapeutics
drugs
evercore isi
fda
gene therapy
hearing loss
heart attack
joe burns
joseph swartz
What
medicines
5
×
cholesterol
drug
medco
lowering
fda
new
twice
aces
acquire
adding
ago
agreed
aiming
alnylam
announced
balance
based
big
billion
bringing
brings
build
cash
ceo
clears
closer
company
compound
data
deal
decibel
drugs
emerged
evidence
filing
flexible
focus
forms
hearing
Language
unset
Current search:
" national blog main "
×
medicines
×
" regeneron pharmaceuticals "
×
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms